Zolbetuximab in Combination with Chemotherapy for Advanced Biliary Tract Cancers
A clinical trial is investigating zolbetuximab combined with either CAPOX or mFOLFOX6 in patients with advanced biliary tract cancers.
Company
Pharmaceutical intelligence for Astellas Pharma Inc with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.